BioCentury
ARTICLE | Clinical News

IV Baremsis amisulpride: Phase III started

March 28, 2016 7:00 AM UTC

Acacia began a double-blind, placebo-controlled, international Phase III trial to evaluate 2 doses of IV Baremsis in about 560 postsurgical patients who develop PONV despite receiving antiemetic proph...